Peptide aptamer targeting Aβ–PrP–Fyn axis reduces Alzheimer’s disease pathologies in 5XFAD transgenic mouse model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Peptide aptamer targeting Aβ–PrP–Fyn axis reduces Alzheimer’s disease pathologies in 5XFAD transgenic mouse model ; volume:80 ; number:6 ; day:7 ; month:5 ; year:2023 ; pages:1-19 ; date:6.2023
Cellular and molecular life sciences ; 80, Heft 6 (7.5.2023), 1-19, 6.2023
- Urheber
-
Ali, Tahir
Klein, Antonia N.
Vu, Alex
Arifin, Maria I.
Hannaoui, Samia
Gilch, Sabine
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00018-023-04785-w
- URN
-
urn:nbn:de:101:1-2023092113462412859731
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ali, Tahir
- Klein, Antonia N.
- Vu, Alex
- Arifin, Maria I.
- Hannaoui, Samia
- Gilch, Sabine
- SpringerLink (Online service)
Ähnliche Objekte (12)
Delta-secretase triggers Alzheimer’s disease pathologies in wild-type hAPP/hMAPT double transgenic mice
Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice
Modeling Alzheimer’s disease in transgenic rats
Management of oxidative stress and other pathologies in Alzheimer’s disease
A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer’s disease
Interleukin-1 mediates Alzheimer and Lewy body pathologies
Modulation of inflammation in transgenic models of Alzheimer’s disease
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline
Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults
Delta-secretase triggers Alzheimer’s disease pathologies in wild-type hAPP/hMAPT double transgenic mice
Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice
Modeling Alzheimer’s disease in transgenic rats
Management of oxidative stress and other pathologies in Alzheimer’s disease
A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer’s disease
Interleukin-1 mediates Alzheimer and Lewy body pathologies
Modulation of inflammation in transgenic models of Alzheimer’s disease
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline
Age, vascular disease, and Alzheimer’s disease pathologies in amyloid negative elderly adults
Delta-secretase triggers Alzheimer’s disease pathologies in wild-type hAPP/hMAPT double transgenic mice
Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice
Modeling Alzheimer’s disease in transgenic rats
Management of oxidative stress and other pathologies in Alzheimer’s disease
A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer’s disease
Interleukin-1 mediates Alzheimer and Lewy body pathologies
Modulation of inflammation in transgenic models of Alzheimer’s disease
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
Interpretable classification of Alzheimer’s disease pathologies with a convolutional neural network pipeline